The National Institute of Mental Health (NIMH) invites research proposals to advance and scale HIV testing, prevention, and care services delivered through pharmacists and pharmacies in US and/or global settings. This grant aims to capacitate and transform the role of pharmacy professionals in HIV service delivery. A key focus is on developing and improving training curricula for pharmacy students, pharmacists, and pharmacy systems to ensure comprehensive HIV services are provided with ease, equity, and effectiveness. This opportunity uses the R01 grant mechanism, making it suitable for projects with existing preliminary data, large-scale clinical trials, or extensive longitudinal analyses. It differs from the R21 mechanism, which is for pilot interventions or those without preliminary data.
Opportunity ID: 353853
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-25-185 |
Funding Opportunity Title: | Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Food and Nutrition Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 29, 2024 |
Last Updated Date: | Apr 29, 2024 |
Original Closing Date for Applications: | Aug 13, 2024 |
Current Closing Date for Applications: | Aug 13, 2024 |
Archive Date: | Sep 18, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses County governments Independent school districts Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public and State controlled institutions of higher education State governments City or township governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-185.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00286124 | Jul 13, 2024 | Aug 13, 2024 | View |
Package 1
Mandatory forms
353853 RR_SF424_5_0-5.0.pdf
353853 PHS398_CoverPageSupplement_5_0-5.0.pdf
353853 RR_OtherProjectInfo_1_4-1.4.pdf
353853 PerformanceSite_4_0-4.0.pdf
353853 RR_KeyPersonExpanded_4_0-4.0.pdf
353853 PHS398_ResearchPlan_5_0-5.0.pdf
353853 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353853 RR_Budget_3_0-3.0.pdf
353853 RR_SubawardBudget30_3_0-3.0.pdf
353853 PHS398_ModularBudget_1_2-1.2.pdf
353853 PHS_AssignmentRequestForm_3_0-3.0.pdf